China Dasheng Biotechnology Performance
| CDBTDelisted Stock | USD 0.04 0.00 0.00% |
The firm shows a Beta (market volatility) of -12.98, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning China Dasheng are expected to decrease by larger amounts. On the other hand, during market turmoil, China Dasheng is expected to outperform it. China Dasheng Biotec right now shows a risk of 0.0%. Please confirm China Dasheng Biotec total risk alpha, as well as the relationship between the potential upside and kurtosis , to decide if China Dasheng Biotec will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days China Dasheng Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, China Dasheng is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Price Earnings Ratio | 1.25 | |
| Total Cashflows From Investing Activities | -3.9 M |
China |
China Dasheng Relative Risk vs. Return Landscape
If you would invest 4.24 in China Dasheng Biotechnology on October 4, 2025 and sell it today you would earn a total of 0.00 from holding China Dasheng Biotechnology or generate 0.0% return on investment over 90 days. China Dasheng Biotechnology is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than China, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
China Dasheng Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for China Dasheng's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as China Dasheng Biotechnology, and traders can use it to determine the average amount a China Dasheng's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CDBT |
Based on monthly moving average China Dasheng is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of China Dasheng by adding China Dasheng to a well-diversified portfolio.
China Dasheng Fundamentals Growth
China Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of China Dasheng, and China Dasheng fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on China Pink Sheet performance.
| Return On Equity | 0.39 | |||
| Return On Asset | 0.2 | |||
| Profit Margin | 0.31 % | |||
| Operating Margin | 0.34 % | |||
| Current Valuation | 8.1 M | |||
| Price To Earning | 0.33 X | |||
| Price To Book | 0.47 X | |||
| Price To Sales | 0.17 X | |||
| Revenue | 16.29 M | |||
| EBITDA | 7.72 M | |||
| Cash And Equivalents | 10.41 M | |||
| Cash Per Share | 0.35 X | |||
| Total Debt | 1.46 M | |||
| Book Value Per Share | 0.64 X | |||
| Cash Flow From Operations | 4.1 M | |||
| Earnings Per Share | 0.03 X | |||
| Total Asset | 20.25 M | |||
| Retained Earnings | 14.21 M | |||
| Current Asset | 14.77 M | |||
| Current Liabilities | 2.23 M | |||
About China Dasheng Performance
Assessing China Dasheng's fundamental ratios provides investors with valuable insights into China Dasheng's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the China Dasheng is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
China Dasheng Biotechnology Company, together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the Peoples Republic of China. China Dasheng Biotechnology Company is based in Lanzhou, China. China Dasheng is traded on OTC Exchange in the United States.Things to note about China Dasheng Biotec performance evaluation
Checking the ongoing alerts about China Dasheng for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for China Dasheng Biotec help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| China Dasheng Biotec is not yet fully synchronised with the market data | |
| China Dasheng Biotec has some characteristics of a very speculative penny stock | |
| China Dasheng Biotec has a very high chance of going through financial distress in the upcoming years |
- Analyzing China Dasheng's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether China Dasheng's stock is overvalued or undervalued compared to its peers.
- Examining China Dasheng's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating China Dasheng's management team can have a significant impact on its success or failure. Reviewing the track record and experience of China Dasheng's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of China Dasheng's pink sheet. These opinions can provide insight into China Dasheng's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in China Pink Sheet
If you are still planning to invest in China Dasheng Biotec check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Dasheng's history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |